Patient perspectives on biosimilar insulin

Journal of Diabetes Science and Technology

Volumn 8, Issue 1, 2014, Pages 23-25

  Wilkins, Alasdair R ^a   Venkat, Manu V ^a   Brown, Adam S ^a   Dong, Jessica P ^a   Ran, Nina A ^a   Hirsch, James S ^a   Close, Kelly L ^a  

^a Close Concerns Inc   (United States)

Author keywords

Biosimilar insulin; Costs; Diabetes; Insulin formulations; Insulin therapy

Indexed keywords

BIOSIMILAR AGENT; BIOSIMILAR INSULIN; INSULIN; INSULIN LISPRO; UNCLASSIFIED DRUG;

CLINICAL STUDY; COMORBIDITY; CONFERENCE PAPER; COST CONTROL; DRUG COST; DRUG DELIVERY DEVICE; DRUG EFFICACY; DRUG SAFETY; EDUCATION PROGRAM; FOLLOW UP; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; IMMUNOGENICITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIFESTYLE MODIFICATION; MARKETING; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SATISFACTION; RISK FACTOR; SATISFACTION; WEIGHT GAIN;

EID: 84900546010     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296813515132     Document Type: Conference Paper

References (4)

1. Sanofi. Sanofi first quarter 2012 press release: Strong performance in Q1 2012 including Genzyme contribution. Available at: http://sanofi.mediaroom.com/ index.php?s=33507&item=127476. Accessed October 31, 2013.
2. Rotenstein LS, Ran N, Shivers JP, Yarchoan M, Close KL. Opportunities and Challenges for Biosimilars: What's on the Horizon in the Global Insulin Market? Available at: http://clinical.diabetesjournals.org/content/30/4/138.full#ref- 59. Accessed October 30, 2013.
3. Calo-Fernández B, Martínez-Hurtado JL. Biosimilars: Company Strategies to Capture Value from the Biologics Market. Available at: http://www.mdpi.com/1424-8247/5/12/1393. Accessed October 30, 2013.
4. IMS Health. Shaping the Biosimilars Opportunity: A Global Perspective on the Evolving Biosimilars Landscape. Available at: http://www.imshealth.com/ims/ Global/Content/Home%20Page%20Content/IMS%20News/Biosimilars-Whitepaper.pdf. Accessed October 30, 2013.